Concord Asset Management (Virginia)’s AbbVie ABBV Stock Holding History

Concord Asset Management (Virginia)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.31M	Buy	6,012 +393	+7%	+$87.2K	0.22%	87
2025 Q4	$1.28M	Sell	5,619 -8	-0.1%	-$1.82K	0.22%	88
2025 Q3	$1.3M	Sell	5,627 -2,132	-27%	-$434K	0.24%	84
2025 Q2	$1.44M	Buy	7,759 +1,691	+28%	+$314K	0.22%	105
2025 Q1	$1.07M	Sell	6,068 -22,087	-78%	-$4.29M	0.24%	89
2024 Q4	$5M	Buy	28,155 +1,550	+6%	+$285K	1.1%	22
2024 Q3	$5.25M	Buy	26,605 +2,537	+11%	+$473K	1.19%	23
2024 Q2	$4.13M	Buy	24,068 +3,078	+15%	+$510K	1.02%	25
2024 Q1	$3.82M	Buy	20,990 +3,321	+19%	+$572K	1.01%	28
2023 Q4	$2.74M	Buy	17,669 +7,284	+70%	+$1.06M	0.81%	31
2023 Q3	$1.55M	Buy	10,385 +3,141	+43%	+$461K	0.52%	38
2023 Q2	$976K	Buy	7,244 +1,614	+29%	+$237K	0.34%	45
2023 Q1	$897K	Buy	+5,630	New	+$861K	0.37%	38

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Concord Asset Management (Virginia)'s ABBV Position: Q1 2026 in Review

Concord Asset Management (Virginia) increased its AbbVie (ABBV) stake by 7% in Q1 2026, buying an estimated $87.2K and bringing the position to 6,012 shares worth $1.31M. The position accounts for 0.22% of the portfolio, ranked #87.

Concord Asset Management (Virginia) first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.25M in Q3 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Concord Asset Management (Virginia) held 6,012 shares of AbbVie worth $1.31M as of Q1 2026.
Concord Asset Management (Virginia) bought 393 AbbVie shares in Q1 2026, an estimated $87.2K.
AbbVie made up 0.22% of Concord Asset Management (Virginia)'s portfolio in Q1 2026, its #87 holding.
Concord Asset Management (Virginia) first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Concord Asset Management (Virginia)'s AbbVie position peaked at $5.25M in Q3 2024.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Concord Asset Management (Virginia)'s 13F filing for Q1 2026, filed 1 May 2026.